BioLASCO Taiwan Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BioLASCO Taiwan Co Ltd with three other
companies in this sector in TAIWAN :
sales of 287.20 million Taiwanese Dollars [US$10.37 million]
of which 91%
Foresee Pharmaceuticals Co Ltd
(230.44 million Taiwanese Dollars [US$8.32 million]
of which 100%
was Anticancer products), and
Applied Biocode Corp
(299.02 million Taiwanese Dollars [US$10.80 million]
of which 89%
was Sales Revernue).
Sales levels dropped significantly in the first
quarter of 2021 versus the previous year's first quarter.
During the first
quarter of 2021, sales at BioLASCO Taiwan Co Ltd totalled
48.89 million Taiwanese Dollars .
This is a drop of 46.4%
from the 91.13 million Taiwanese Dollars in sales at the company during the first quarter in 2020.
BioLASCO Taiwan Co Ltd reported sales of 298.88 million Taiwanese Dollars (US$10.79 million)
December of 2020.
decrease of 13.8%
versus 2019, when the company's sales were 346.69 million Taiwanese Dollars .